NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
Gregory P. Kalemkerian(University of Michigan), Billy W. Loo(Cancer Institute (WIA)), Wallace Akerley(University of Utah), Albert Attia(Breast Cancer Research Foundation), M. Bassetti(University of Wisconsin Carbone Cancer Center), Yanis Boumber(Fox Chase Cancer Center), Roy H. Decker(Yale Cancer Center), M.C. Dobelbower(University of Alabama at Birmingham), Afshin Dowlati(Cleveland Clinic), Robert J. Downey(Memorial Sloan Kettering Cancer Center), Charles Florsheim(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Apar Kishor Ganti(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), J.C. Grecula(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Matthew A. Gubens(UCSF Helen Diller Family Comprehensive Cancer Center), Christine L. Hann(Sidney Kimmel Comprehensive Cancer Center), James A. Hayman(University of Michigan), Rebecca S. Heist(Massachusetts General Hospital), Marianna Koczywas(City Of Hope National Medical Center), Robert E. Merritt(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Nisha Mohindra(Robert Morris University Illinois), Julian R. Molina(WinnMed), César A. Moran(The University of Texas MD Anderson Cancer Center), Daniel Morgensztern(Barnes-Jewish Hospital), Saraswati Pokharel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David C. Portnoy(St. Jude Children's Research Hospital), Deborah J. Rhodes(WinnMed), Chad G. Rusthoven(University of Colorado Cancer Center), Jacob Sands(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Rafael Santana-Dávila(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Charles C. Williams(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), K Hoffmann(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Miranda Hughes(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 297Open Access
Abstract
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."
Related Papers
No related papers found
Powered by citation graph analysis